chr2-230168917-A-ATTAATT
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP6_ModerateBA1
The NM_080424.4(SP110):c.*206_*207insAATTAA variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.54 ( 21210 hom., cov: 0)
Exomes 𝑓: 0.36 ( 4455 hom. )
Consequence
SP110
NM_080424.4 3_prime_UTR
NM_080424.4 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -1.76
Genes affected
SP110 (HGNC:5401): (SP110 nuclear body protein) The nuclear body is a multiprotein complex that may have a role in the regulation of gene transcription. This gene is a member of the SP100/SP140 family of nuclear body proteins and encodes a leukocyte-specific nuclear body component. The protein can function as an activator of gene transcription and may serve as a nuclear hormone receptor coactivator. In addition, it has been suggested that the protein may play a role in ribosome biogenesis and in the induction of myeloid cell differentiation. Alternative splicing has been observed for this gene and three transcript variants, encoding distinct isoforms, have been identified. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP6
Variant 2-230168917-A-ATTAATT is Benign according to our data. Variant chr2-230168917-A-ATTAATT is described in ClinVar as [Benign]. Clinvar id is 369333.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.586 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.536 AC: 79256AN: 147956Hom.: 21215 Cov.: 0
GnomAD3 genomes
AF:
AC:
79256
AN:
147956
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.358 AC: 96407AN: 269396Hom.: 4455 Cov.: 0 AF XY: 0.358 AC XY: 51407AN XY: 143536
GnomAD4 exome
AF:
AC:
96407
AN:
269396
Hom.:
Cov.:
0
AF XY:
AC XY:
51407
AN XY:
143536
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.536 AC: 79282AN: 148030Hom.: 21210 Cov.: 0 AF XY: 0.532 AC XY: 38278AN XY: 71974
GnomAD4 genome
AF:
AC:
79282
AN:
148030
Hom.:
Cov.:
0
AF XY:
AC XY:
38278
AN XY:
71974
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Hepatic veno-occlusive disease-immunodeficiency syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at